Pathways to Cardiovascular Therapeutics

心血管治疗途径

基本信息

批准号：
8986055
负责人：
Joshua M Hare
金额：
$ 3万
依托单位：
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-07-01 至 2016-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8986055
关键词：
American Heart Association Anniversary Area Award Back Biology Budgets Cardiac Cardiac development Cardiology Cardiovascular system Cell Therapy Cells Collaborations Communities Disabled Persons Disease Disease Progression Ensure Epigenetic Process Equilibrium Event Family Fostering Functional disorder Funding Future Goals Grant Heart Diseases Heart failure Homeostasis Individual Institutes Investments Israel Learning Left Life Location Louisiana Medical Research Medical center MicroRNAs Minority Molecular National Heart, Lung, and Blood Institute Oral Pathway interactions Recruitment Activity Request for Proposals Research Research Personnel Schedule Science Scientist Secure Signal Pathway Site Stem Cell Research Therapeutic Time Tissue Engineering Travel Uncertainty Underrepresented Minority Universities Utah Work abstracting career combat cost design experience follow-up gene therapy heart metabolism induced pluripotent stem cell lectures medical specialties meetings methionylmethionine next generation novel outreach posters programs public health relevance success symposium therapeutic target trend

项目摘要

DESCRIPTION (provided by applicant): This is a new application for the Annual Summer 2015 Symposium of the Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA). This conference has had continuous support from the NHLBI for the last 10 years and this will be the 11th Anniversary meeting. Support from the NHLBI has helped foster a meeting that has become the "go to" conference dealing with molecular cardiovascular biology and disease. It represents its sponsor, the BCVS of the AHA, which is the world's leading organization of cardiovascular scientists. This conference started originally two decades ago as the Council held a Molecular Cardiology conference in 1991 and then had several meetings initially hailed as the Snowbird Conference as it was held during the summer at Snowbird, Utah. The meeting became an annual event in 2002 and since 2004 this conference has been recognized as a permanent, recurring scientific meeting of the AHA and which is when R13 funding also commenced. The conference in recent years has added translational topics as well as the "bread and butter" of this meeting, which is basic molecular cardiovascular research. The conference has always attracted the leading researchers in fields such as microRNA, cardiac gene and cell therapy, cardiac development and most recently, tissue engineering and iPS cells. The attendance of this conference has climbed every year and in 2014 we had an all-time high attendance of over 600. As in past years, the conference will be held in July and this year will return to New Orleans (the site of the 2011 and 2012 meetings) after two years in Las Vegas. The meeting will be held at the Hilton New Orleans Riverside, New Orleans, LA. The planned agenda represents an ambitious, fast-paced meeting with 14 sessions over 4 days (July 13-16, 2015) including the Keynote lecture by Dr. Eric Olson. Young cardiovascular scientists will be highlighted as well through invited talks in each session and Posters will be presented over the course of 3 days of the conference. Organizers of this meeting are Drs. Asa Gustafsson (UCSD), Anthony Rosenzweig (Beth Israel Deaconess Medical Center) and David J. Lefer (Louisiana State University). The proposal request constitutes approximately 7% of the total meeting budget and as we have done over the last several years, support from this application will be used toward Cardiovascular Outreach Awards (minority travel awards) and Young Investigator Travel Awards.

描述（由应用程序提供）：这是美国心脏协会（AHA）的基本心血管科学基础科学（BCV）2015年度夏季研讨会的新应用。在过去的十年中，这次会议一直得到NHLBI的持续支持，这将是11周年会议。 NHLBI的支持帮助促进了一次会议，该会议已成为涉及分子心血管生物学和疾病的“参加”会议。它代表其赞助商，即AHA的BCV，这是世界领先的心血管科学家组织。这次会议最初是在二十年前开始的，当时理事会于1991年举行了一次分子心脏病学会议，然后在夏季在犹他州的雪鸟（Snowbird）举行的那样，最初举行了几次会议。该会议成为2002年的年度活动，自2004年以来，该会议被公认为是AHA的永久性，经常性的科学会议，而R13资金也开始。近年来的会议增加了转化主题以及这次会议的“面包和黄油”，这是基本的分子心血管研究。该会议一直吸引着诸如MicroRNA，心脏基因和细胞疗法，心脏发育以及最近的组织工程和IPS细胞等领域的领先研究人员。这次会议的出席率每年都在攀升，2014年，我们有600多人的历史上的出席人数。与过去的几年一样，在拉斯维加斯两年后，该会议将于7月举行，今年将返回新奥尔良（2011年和2012年会议的地点）。会议将在洛杉矶新奥尔良希尔顿新奥尔良河滨举行。计划中的议程代表了一次雄心勃勃的快节奏会议，在4天内（2015年7月13日至16日）举行了14次会议，其中包括埃里克·奥尔森（Eric Olson）博士的主题演讲。年轻的心血管科学家也将通过每个会议中的邀请演讲来强调，并在会议的3天内介绍海报。这次会议的组织者是Drs。 Asa Gustafsson（UCSD），Anthony Rosenzweig（Beth Israel Deaconess Medical Center）和David J. Lefer（路易斯安那州立大学）。该提案请求约占会议总预算的大约7％，并且正如我们在过去几年中所做的那样，该申请的支持将用于心血管外展奖（少数民族旅行奖）和年轻的调查员旅行奖。